Unknown

Dataset Information

Evaluation of three barrier-type closed system transfer devices using the 2015 NIOSH vapor containment performance draft protocol.


ABSTRACT:

Background

Closed System Transfer Devices (CSTD) have been developed to reduce healthcare worker exposure to hazardous drugs during medication handling. To evaluate CSTD performance in preventing the escape of drug vapors, the National Institute for Occupational Safety and Health (NIOSH) developed a 2015 draft testing protocol incorporating two compounding tasks utilizing 70% isopropyl alcohol (IPA) as a medication surrogate.

Purpose

The objective of this study was to evaluate the performance of three CSTDs (Chemolock [ICU Medical Inc., San Clemente, CA], PhaSeal [BD, Franklin Lakes, NJ], and Equashield [Equashield, Port Washington, NY]) in preventing the escape of drug vapor in accordance with the 2015 NIOSH draft protocol during simulated compounding and administration tas

SUBMITTER: Szkiladz A 

PROVIDER: S-EPMC8925293 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature